A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcoma.
Araki Y, Asano N, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Higuchi T, Abe K, Taniguchi Y, Yonezawa H, Morinaga S, Asano Y, Yoshida T, Hanayama R, Matsuzaki J, Ochiya T, Kawai A, Tsuchiya H.
Araki Y, et al. Among authors: hayashi k.
Oncol Lett. 2023 Apr 13;25(6):222. doi: 10.3892/ol.2023.13808. eCollection 2023 Jun.
Oncol Lett. 2023.
PMID: 37153065
Free PMC article.